Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025)
Certified by Founder
Lodge
Biorithm
start up
Singapore
- Singapore
- 19/12/2023
- Series A
- $3,500,000
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine.
Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data.
Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
- Industry Medical Device
- Website https://www.bio-rithm.com/
- LinkedIn https://www.linkedin.com/company/biorithm/about/
Related People
Amrish NairFounder
Singapore -
Singapore
Signal processing engineer with a focus on sparse sampling and biomedical applications. Experience with academia and interdisciplinary research with clinicians.
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)